Barclays Gives IBM a Bullish Overweight Rating – Software Strength & Quantum Upside in Focus
Barclays rates IBM Overweight with $350 target (~18% upside), citing steady software growth, strong margins, and quantum upside.
/ 21 items
#IBM↓
IBM Pours $10 Billion to Chase the Holy Grail of Quantum Computing
IBM is investing $10B in quantum computing to build powerful new computers by 2029 that could solve complex real-world problems.
IBM and GlobalFoundries Secure Over $1.3 Billion in CHIPS Funding to Build America’s Quantum Chip Manufacturing Base
IBM will build America’s first dedicated quantum foundry with $2B backing, while GlobalFoundries launches Quantum Technology Solutions supported by a $375M CHIPS award.
Trump Administration Awards $2 Billion to Quantum Computing Firms, Takes Equity Stakes
The Trump administration is awarding $2 billion in grants to nine quantum computing companies, including IBM, and will take equity stakes in the firms to strengthen US tech leadership.
IBM Q1 2026 Earnings Beat Estimates, But Shares Drop on AI Jitters
IBM had a strong Q1 2026: revenue up 9%, profits beat expectations, AI and cloud drove growth, but stock fell on AI fears.
UBS Upgrades IBM to Neutral – AI Fears Largely Priced In, Mainframes Stay Sticky
UBS upgrades IBM from Sell to Neutral, keeps $236 price target. After a 22% drop, analysts see better risk/reward and limited AI threat to IBM's mainframe business.